DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RADIUM RA-223 DICHLORIDE

« Back to Dashboard

All Clinical Trials for Radium Ra-223 Dichloride

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00699751	A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases	Completed	Bayer	Phase 3	2008-06-01	ALSYMPCA (ALpharadin in SYMPtomatic Prostate CAncer) is an international Phase III clinical study to evaluate the efficacy and safety of Radium-223 dichloride in patients with hormone refractory prostate cancer and skeletal metastases.
NCT01516762	Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases	No longer available	Bayer	N/A	1969-12-31	This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC patients diagnosed with symptomatic bone metastasis and to collect additional short and long term safety data on the product.
NCT01618370	Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases	Completed	Bayer	Phase 3	2012-07-01	This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product.

Clinical Trial Conditions for Radium Ra-223 Dichloride

Condition Name

Condition Name for Radium Ra-223 Dichloride
Intervention	Trials
Prostatic Neoplasms	7
Bone Metastases	4
Castration-Resistant Prostate Carcinoma	3

Condition MeSH

Condition MeSH for Radium Ra-223 Dichloride
Intervention	Trials
Prostatic Neoplasms	22
Neoplasm Metastasis	8
Carcinoma	6

Clinical Trial Locations for Radium Ra-223 Dichloride

Trials by Country

Trials by Country for Radium Ra-223 Dichloride
Location	Trials
United States	186
Italy	62
United Kingdom	59
Germany	53
Spain	34

Trials by US State

Trials by US State for Radium Ra-223 Dichloride
Location	Trials
New York	11
California	11
Maryland	9
Pennsylvania	9
Washington	8

Clinical Trial Progress for Radium Ra-223 Dichloride

Clinical Trial Phase

Clinical Trial Phase for Radium Ra-223 Dichloride
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	4
Phase 2	14

Clinical Trial Status

Clinical Trial Status for Radium Ra-223 Dichloride
Clinical Trial Phase	Trials
Not yet recruiting	12
Active, not recruiting	8
Recruiting	6

Clinical Trial Sponsors for Radium Ra-223 Dichloride

Sponsor Name

Sponsor Name for Radium Ra-223 Dichloride
Sponsor	Trials
Bayer	18
National Cancer Institute (NCI)	5
Carolina Research Professionals, LLC	2

Sponsor Type

Sponsor Type for Radium Ra-223 Dichloride
Sponsor	Trials
Industry	23
Other	13
NIH	5